Simply Good Foods Company (SMPL) reported earnings on Thur 9 Apr 26 (b/o)

• Sector: Consumer Defensive
• Industry: Packaged Foods
• Full Time Employees: 328
• Incorporated in 2017 
• Headquartered in Denver, Colorado
• https://www.thesimplygoodfoodscompany.com

The maker of Atkins diet meals tumbled 19% after reported fiscal second quarter revenue and adjusted earnings before interest, taxes, depreciation and amortization, and fiscal third quarter guidance for revenue and EBITDA, fell far short of Wall Street consensus estimates, according to FactSet data.

Simply Good Foods beats by $0.05, misses on revs; guides Q3 revs below consensus; guides FY26 revs below consensus 

• Reports Q2 (Feb) earnings of $0.45 per share, excluding non-recurring items, $0.05 better than the FactSet Consensus of $0.40; revenues fell 9.4% year/year to $326.01 mln vs the $345.36 mln FactSet Consensus.
• Co issues downside guidance for Q3, sees Q3 revs of $329-$338 mln vs. $379.97 mln FactSet Consensus.
• Co issues downside guidance for FY26, sees FY26 revs of $1.31-$1.35 bln vs. $1.44 bln FactSet Consensus. Adjusted EBITDA expected to range between $217 to $225 million, or -22% to -19% yr/yr.

• Retail takeaway slowed sharply; company-estimated consumption down 6.4% versus Q1’s stronger trends.
• Quest grew 2.4% with chips up 14%, but bar baseline velocities weakened.
• Atkins consumption fell 23.4% on distribution losses and prior pullback in marketing support.
• OWYN down 2.4%; product quality issues and poor velocities triggering expected distribution losses.

• Main concern: execution risk around multi-brand turnaround while protein input costs remain elevated.
• Weak quarter, driven by broad volume declines, margin compression, and brand execution issues.

SPI Energy (SPI) : 9-year performance

SPI Energy Co. Ltd. is a global renewable energy company, which engages in the provision of solar storage and electric vehicle solutions. It operates through the following segments: Renewable Energy Solutions, Solar Projects Development, Electric Vehicles, and Others.

• Sector: Technology
• Industry: Solar
• Full Time Employees: 316
• founded in 2006 and is headquartered in Sacramento, CA
• https://www.spigroups.com

Ticker:  SPI

 

 

 

vTv Therapeutics (VTVT) : 9-year performance

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program.

• Founded: 2015
• Headquarters: High Point, North Carolina
• Employees: 16
• vtvtherapeutics.com

 

 

 

 

 

ImmunityBio (IBRX) : 9-year performance

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. 

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 673
• Founded by Patrick Soon-Shiong in 2014 
• Headquartered in San Diego, California
• https://immunitybio.com

Ticker: IBRX 

• 2 months later (10 Dec 24)

Evoke Pharma (EVOK) : New FDA Market Exclusivity For Gimoti Nasal Spray

  

 

The FDA has granted new drug product exclusivity to Evoke Pharma Inc's (NASDAQ: EVOK) Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults.

Evoke now has exclusive marketing rights over three (3) years from the original date of approval under the Hatch-Waxman Act to protect the product from generic drug competition.

In addition to the market exclusivity, Evoke maintains a robust patent estate, with currently two Orange book-listed patents that expire in 2029 and 2030.

The Company has also been granted gender-specific patents in the EU, Japan, and Mexico until 2032.

Furthermore, if approved, Evoke has other pending patent applications with individual expiration dates of 2032, 2037, and 2038.

Laredo Petroleum (LPI) : 9-year performance

Vera Bradley (VRA) reported earnings on Wed 6 June 2018 (b/o)

** charts before earnings **

 

** charts after earnings **

 

Vera Bradley beats by $0.06, reports revs in-line; guides Q2 above consensus; raises FY19 EPS, guides revs in-line

• Reports Q1 (Apr) loss of $0.04 per share, $0.06 better thanthe Capital IQ Consensus of ($0.10); revenues fell 9.9% year/year to $86.6 mln vs the $86.21 mln Capital IQ Consensus.
• Co issues upside guidancefor Q2, sees EPS of $0.15-0.17 vs. $0.09 Capital IQ Consensus Estimate; sees Q2 revs of $111-116 mln vs. $100.45 mln Capital IQ Consensus Estimate.
• Co issues in-line guidancefor FY19, sees EPS of $0.40-0.50 from $0.35-0.45 vs. $0.42 Capital IQ Consensus Estimate; sees FY19 revs of $405-422 mln from $405-425 mln vs. $411.34 mln Capital IQ Consensus Estimate. 
• "We are pleased that our first quarter results exceeded both expectations and prior year performance, primarily driven by a higher-than-planned gross margin rate, largely due to reduced clearance and improved full-price selling, as well as better-than-expected expense leverage. Revenues were in line with our guidance."